On Friday, October 21, 2022, Lieff Cabraser partner David Rudolph will speak as part of an upcoming Practising Law Institute in-person and virtual program on California Privacy Law 2022. David will present material on the “Outside Counsel Perspective,” discussing key privacy litigation risks faced by companies, providing an understanding of the plaintiff perspective, and analyzing what steps companies can take to minimize risk.
For more information regarding speakers, agenda, and registration, visit the Practising Law Institute website.
About David Rudolph
A partner in our San Francisco office, David Rudolph is a member of the firm’s Cybersecurity and Data Privacy and Antitrust and Intellectual Property practice groups. He has extensive experience litigating core technical issues in privacy cases, including in In re Anthem, Inc. Data Breach Litigation, MDL No. 2617 (N.D. Cal.), arising from a data breach that affected nearly 80 million of Anthem’s members, and in Campbell v. Facebook, Inc., No. 5:13-cv- 5996 (N.D. Cal.), in which Facebook users asserted that Facebook violated their privacy rights by scanning their private email messages.
David has represented end-payor classes in pharmaceutical antitrust litigation, including in the Cipro drug antitrust cases, the Restasis antitrust litigation, and the Generic Pharmaceuticals Price-Fixing cases. In 2017, David shared the “Outstanding Private Practice Antitrust Achievement” award from the American Antitrust Institute for his work on the Cipro case. He also represents plaintiffs in In re Domestic Airline Travel Antitrust Litigation (D.D.C.), a class action lawsuit alleging a conspiracy by United, American, Delta, and Southwest to artificially inflate domestic airline ticket prices by artificially limiting seating capacity.